Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies

Diane Braguer, Jean Marc Barret, Hayley McDaid, Anna Kruczynski

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Vinflunine is an innovative microtubule inhibitor of the vinca alkaloid class with distinct tubulin-binding properties. Preclinical evaluation of this novel microtubule inhibitor has shown superior antitumor activity against a broad spectrum of tumor types in vitro and in vivo, in comparison with other vinca alkaloids. The antitumor effect of vinflunine is largely attributable to its modulation of microtubule dynamics, and is mediated by its ability to induce apoptosis in target cells. At non-cytotoxic concentrations, vinflunine also exerts antiangiogenic and antivascular activity. The favorable preclinical profile of vinflunine, in addition to its synergism with a variety of other therapeutic modalities, justifies further clinical development of this compound.

Original languageEnglish (US)
Pages (from-to)S13-S21
JournalSeminars in oncology
Issue numberSUPPL 3
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies'. Together they form a unique fingerprint.

Cite this